There are significant opportunities for pharma and biotech companies to support patients in the Middle East, but how do companies navigate such a culturally diverse region?
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
With people’s health and lives at stake, maintaining a resilient pharmaceutical supply chain to ensure the timely delivery of life-saving medication is critical.
On International Women’s Day, pharmaphorum looks back to an interview with data infrastructure and analytics company Kalderos’ CEO Angie Franks, a longtime healthcare executive, speaking wi
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh